Canine and feline cutaneous mast cell tumour: a comprehensive review of treatments and outcomes

Abstract

Mast cell tumour (MCT) or mastocytoma is one of the most frequent malignant cutaneous tumours in the dog and the second most frequent in the cat. In dogs, some factors, like age and breed, are known to be related to the occurrence of this tumour, while no gender tendency was identified. In cats, the Siamese has demonstrated differential predisposition to the disease. An increased MCT frequency is also suggested in other breeds in England, like Burmese, Russian blue and Ragdoll. No gender predilection has yet been established.

Several mast cell tumour therapeutic approaches have been proposed in the past years for dogs and cats, resulting in very distinct outcomes. This review intends to address existent information about the relationship between the MCTs treatments and the subsequent prognosis and survival times in dogs and in cats diagnosed with MCTs.